Request for Covid-19 Impact Assessment of this Report
The United States Ergotamine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ergotamine market, reaching US$ million by the year 2028. As for the Europe Ergotamine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ergotamine players cover Sanofi, 3M, AstraZeneca, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ergotamine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Ergotamine Tartrate
Dichloroergotamine
Ergotamine Caffeine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
3M
AstraZeneca
Novartis
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ergotamine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ergotamine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ergotamine by Country/Region, 2017, 2022 & 2028
2.2 Ergotamine Segment by Type
2.2.1 Ergotamine Tartrate
2.2.2 Dichloroergotamine
2.2.3 Ergotamine Caffeine
2.3 Ergotamine Sales by Type
2.3.1 Global Ergotamine Sales Market Share by Type (2017-2022)
2.3.2 Global Ergotamine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ergotamine Sale Price by Type (2017-2022)
2.4 Ergotamine Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Ergotamine Sales by Application
2.5.1 Global Ergotamine Sale Market Share by Application (2017-2022)
2.5.2 Global Ergotamine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ergotamine Sale Price by Application (2017-2022)
3 Global Ergotamine by Company
3.1 Global Ergotamine Breakdown Data by Company
3.1.1 Global Ergotamine Annual Sales by Company (2020-2022)
3.1.2 Global Ergotamine Sales Market Share by Company (2020-2022)
3.2 Global Ergotamine Annual Revenue by Company (2020-2022)
3.2.1 Global Ergotamine Revenue by Company (2020-2022)
3.2.2 Global Ergotamine Revenue Market Share by Company (2020-2022)
3.3 Global Ergotamine Sale Price by Company
3.4 Key Manufacturers Ergotamine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ergotamine Product Location Distribution
3.4.2 Players Ergotamine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ergotamine by Geographic Region
4.1 World Historic Ergotamine Market Size by Geographic Region (2017-2022)
4.1.1 Global Ergotamine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ergotamine Annual Revenue by Geographic Region
4.2 World Historic Ergotamine Market Size by Country/Region (2017-2022)
4.2.1 Global Ergotamine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ergotamine Annual Revenue by Country/Region
4.3 Americas Ergotamine Sales Growth
4.4 APAC Ergotamine Sales Growth
4.5 Europe Ergotamine Sales Growth
4.6 Middle East & Africa Ergotamine Sales Growth
5 Americas
5.1 Americas Ergotamine Sales by Country
5.1.1 Americas Ergotamine Sales by Country (2017-2022)
5.1.2 Americas Ergotamine Revenue by Country (2017-2022)
5.2 Americas Ergotamine Sales by Type
5.3 Americas Ergotamine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ergotamine Sales by Region
6.1.1 APAC Ergotamine Sales by Region (2017-2022)
6.1.2 APAC Ergotamine Revenue by Region (2017-2022)
6.2 APAC Ergotamine Sales by Type
6.3 APAC Ergotamine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ergotamine by Country
7.1.1 Europe Ergotamine Sales by Country (2017-2022)
7.1.2 Europe Ergotamine Revenue by Country (2017-2022)
7.2 Europe Ergotamine Sales by Type
7.3 Europe Ergotamine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ergotamine by Country
8.1.1 Middle East & Africa Ergotamine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ergotamine Revenue by Country (2017-2022)
8.2 Middle East & Africa Ergotamine Sales by Type
8.3 Middle East & Africa Ergotamine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ergotamine
10.3 Manufacturing Process Analysis of Ergotamine
10.4 Industry Chain Structure of Ergotamine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ergotamine Distributors
11.3 Ergotamine Customer
12 World Forecast Review for Ergotamine by Geographic Region
12.1 Global Ergotamine Market Size Forecast by Region
12.1.1 Global Ergotamine Forecast by Region (2023-2028)
12.1.2 Global Ergotamine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ergotamine Forecast by Type
12.7 Global Ergotamine Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Ergotamine Product Offered
13.1.3 Sanofi Ergotamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 3M
13.2.1 3M Company Information
13.2.2 3M Ergotamine Product Offered
13.2.3 3M Ergotamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 3M Main Business Overview
13.2.5 3M Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Ergotamine Product Offered
13.3.3 AstraZeneca Ergotamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Ergotamine Product Offered
13.4.3 Novartis Ergotamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Ergotamine Product Offered
13.5.3 Pfizer Ergotamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
14 Research Findings and Conclusion
Table 1. Ergotamine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Ergotamine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Ergotamine Tartrate
Table 4. Major Players of Dichloroergotamine
Table 5. Major Players of Ergotamine Caffeine
Table 6. Global Ergotamine Sales by Type (2017-2022) & (K Units)
Table 7. Global Ergotamine Sales Market Share by Type (2017-2022)
Table 8. Global Ergotamine Revenue by Type (2017-2022) & ($ million)
Table 9. Global Ergotamine Revenue Market Share by Type (2017-2022)
Table 10. Global Ergotamine Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Ergotamine Sales by Application (2017-2022) & (K Units)
Table 12. Global Ergotamine Sales Market Share by Application (2017-2022)
Table 13. Global Ergotamine Revenue by Application (2017-2022)
Table 14. Global Ergotamine Revenue Market Share by Application (2017-2022)
Table 15. Global Ergotamine Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Ergotamine Sales by Company (2020-2022) & (K Units)
Table 17. Global Ergotamine Sales Market Share by Company (2020-2022)
Table 18. Global Ergotamine Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Ergotamine Revenue Market Share by Company (2020-2022)
Table 20. Global Ergotamine Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Ergotamine Producing Area Distribution and Sales Area
Table 22. Players Ergotamine Products Offered
Table 23. Ergotamine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Ergotamine Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Ergotamine Sales Market Share Geographic Region (2017-2022)
Table 28. Global Ergotamine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Ergotamine Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Ergotamine Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Ergotamine Sales Market Share by Country/Region (2017-2022)
Table 32. Global Ergotamine Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Ergotamine Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Ergotamine Sales by Country (2017-2022) & (K Units)
Table 35. Americas Ergotamine Sales Market Share by Country (2017-2022)
Table 36. Americas Ergotamine Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Ergotamine Revenue Market Share by Country (2017-2022)
Table 38. Americas Ergotamine Sales by Type (2017-2022) & (K Units)
Table 39. Americas Ergotamine Sales Market Share by Type (2017-2022)
Table 40. Americas Ergotamine Sales by Application (2017-2022) & (K Units)
Table 41. Americas Ergotamine Sales Market Share by Application (2017-2022)
Table 42. APAC Ergotamine Sales by Region (2017-2022) & (K Units)
Table 43. APAC Ergotamine Sales Market Share by Region (2017-2022)
Table 44. APAC Ergotamine Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Ergotamine Revenue Market Share by Region (2017-2022)
Table 46. APAC Ergotamine Sales by Type (2017-2022) & (K Units)
Table 47. APAC Ergotamine Sales Market Share by Type (2017-2022)
Table 48. APAC Ergotamine Sales by Application (2017-2022) & (K Units)
Table 49. APAC Ergotamine Sales Market Share by Application (2017-2022)
Table 50. Europe Ergotamine Sales by Country (2017-2022) & (K Units)
Table 51. Europe Ergotamine Sales Market Share by Country (2017-2022)
Table 52. Europe Ergotamine Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Ergotamine Revenue Market Share by Country (2017-2022)
Table 54. Europe Ergotamine Sales by Type (2017-2022) & (K Units)
Table 55. Europe Ergotamine Sales Market Share by Type (2017-2022)
Table 56. Europe Ergotamine Sales by Application (2017-2022) & (K Units)
Table 57. Europe Ergotamine Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Ergotamine Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Ergotamine Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Ergotamine Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Ergotamine Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Ergotamine Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Ergotamine Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Ergotamine Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Ergotamine Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Ergotamine
Table 67. Key Market Challenges & Risks of Ergotamine
Table 68. Key Industry Trends of Ergotamine
Table 69. Ergotamine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Ergotamine Distributors List
Table 72. Ergotamine Customer List
Table 73. Global Ergotamine Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Ergotamine Sales Market Forecast by Region
Table 75. Global Ergotamine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Ergotamine Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Ergotamine Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Ergotamine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Ergotamine Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Ergotamine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Ergotamine Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Ergotamine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Ergotamine Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Ergotamine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Ergotamine Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Ergotamine Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Ergotamine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Ergotamine Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Ergotamine Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Ergotamine Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Ergotamine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Ergotamine Revenue Market Share Forecast by Application (2023-2028)
Table 93. Sanofi Basic Information, Ergotamine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Ergotamine Product Offered
Table 95. Sanofi Ergotamine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. 3M Basic Information, Ergotamine Manufacturing Base, Sales Area and Its Competitors
Table 99. 3M Ergotamine Product Offered
Table 100. 3M Ergotamine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. 3M Main Business
Table 102. 3M Latest Developments
Table 103. AstraZeneca Basic Information, Ergotamine Manufacturing Base, Sales Area and Its Competitors
Table 104. AstraZeneca Ergotamine Product Offered
Table 105. AstraZeneca Ergotamine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. AstraZeneca Main Business
Table 107. AstraZeneca Latest Developments
Table 108. Novartis Basic Information, Ergotamine Manufacturing Base, Sales Area and Its Competitors
Table 109. Novartis Ergotamine Product Offered
Table 110. Novartis Ergotamine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Novartis Main Business
Table 112. Novartis Latest Developments
Table 113. Pfizer Basic Information, Ergotamine Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Ergotamine Product Offered
Table 115. Pfizer Ergotamine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Ergotamine
Figure 2. Ergotamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ergotamine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Ergotamine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Ergotamine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Ergotamine Tartrate
Figure 10. Product Picture of Dichloroergotamine
Figure 11. Product Picture of Ergotamine Caffeine
Figure 12. Global Ergotamine Sales Market Share by Type in 2021
Figure 13. Global Ergotamine Revenue Market Share by Type (2017-2022)
Figure 14. Ergotamine Consumed in Hospitals
Figure 15. Global Ergotamine Market: Hospitals (2017-2022) & (K Units)
Figure 16. Ergotamine Consumed in Clinics
Figure 17. Global Ergotamine Market: Clinics (2017-2022) & (K Units)
Figure 18. Ergotamine Consumed in Others
Figure 19. Global Ergotamine Market: Others (2017-2022) & (K Units)
Figure 20. Global Ergotamine Sales Market Share by Application (2017-2022)
Figure 21. Global Ergotamine Revenue Market Share by Application in 2021
Figure 22. Ergotamine Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Ergotamine Revenue Market Share by Company in 2021
Figure 24. Global Ergotamine Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Ergotamine Revenue Market Share by Geographic Region in 2021
Figure 26. Global Ergotamine Sales Market Share by Region (2017-2022)
Figure 27. Global Ergotamine Revenue Market Share by Country/Region in 2021
Figure 28. Americas Ergotamine Sales 2017-2022 (K Units)
Figure 29. Americas Ergotamine Revenue 2017-2022 ($ Millions)
Figure 30. APAC Ergotamine Sales 2017-2022 (K Units)
Figure 31. APAC Ergotamine Revenue 2017-2022 ($ Millions)
Figure 32. Europe Ergotamine Sales 2017-2022 (K Units)
Figure 33. Europe Ergotamine Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Ergotamine Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Ergotamine Revenue 2017-2022 ($ Millions)
Figure 36. Americas Ergotamine Sales Market Share by Country in 2021
Figure 37. Americas Ergotamine Revenue Market Share by Country in 2021
Figure 38. United States Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Ergotamine Sales Market Share by Region in 2021
Figure 43. APAC Ergotamine Revenue Market Share by Regions in 2021
Figure 44. China Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Ergotamine Sales Market Share by Country in 2021
Figure 51. Europe Ergotamine Revenue Market Share by Country in 2021
Figure 52. Germany Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Ergotamine Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Ergotamine Revenue Market Share by Country in 2021
Figure 59. Egypt Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Ergotamine Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Ergotamine in 2021
Figure 65. Manufacturing Process Analysis of Ergotamine
Figure 66. Industry Chain Structure of Ergotamine
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...